Given the roles of STYK1 in the activation of Wnt/β-catenin pathway and pancreatic cancer progression, we evaluated STYK1-driving peptides disrupting STYK1-β-catenin/GSK3β interactions on pancreatic cancer tumorigenesis. This evidence concerns the gene STYK1 and pancreatic neoplasm.